These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 3740536)

  • 1. [Experimental study of the effect of ticlopidine chlorhydrate on the development of atherosclerotic lesions].
    Viver Manresa E; Huguet Redecilla P
    Angiologia; 1986; 38(3):134-49. PubMed ID: 3740536
    [No Abstract]   [Full Text] [Related]  

  • 2. Blood lipid profile in healthy subjects treated with ticlopidine.
    Violi F; Alessandri C; Iuliano L; Ghiselli A; Perrone A; Balsano F
    Atherosclerosis; 1985 Dec; 58(1-3):291-4. PubMed ID: 4091884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro study of ticlopidine, as a model of antisickling action of platelet antiaggregant.
    Sablayrolles M; Wajcman H; Castaigne JP; Labie D
    Haematologia (Budap); 1984; 17(2):199-207. PubMed ID: 6534828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The antiaggregation effect of ticlopidine on blood platelets preliminary results and prospectives for studies in various diseases].
    Andriani A; Chiappetta MG; Fabiani M; Mosiello G; Beni A
    Clin Ter; 1983 Feb; 104(3):219-22. PubMed ID: 6345050
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative study of platelet aggregation measured with 3 different methods (photometric and impedance) in ticlopidine treated patients.
    Lecrubier C; Girard P; Noire P; Samama M
    Agents Actions Suppl; 1984; 15():60-7. PubMed ID: 6592946
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evaluation of platelet aggregation in patients treated with ticlopidine].
    Sbalzarini G; Carniti E; Fiorini L; Iezzi BG
    Clin Ter; 1984 Nov; 111(3):247-50. PubMed ID: 6240365
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of oral ticlopidine on arachidonic acid products in human platelets.
    Bruno JJ; Chang LF; McSpadden MM; Yang D
    Agents Actions Suppl; 1984; 15():76-87. PubMed ID: 6435408
    [No Abstract]   [Full Text] [Related]  

  • 8. [The effects of ticlopidine on platelet aggregation: study on 13 atherosclerotic patients].
    Lenci R; Galante A; Borzi M; Ariganello M; Sommariva L; Filice A; Cannata D
    Clin Ter; 1983 Feb; 104(3):205-9. PubMed ID: 6861457
    [No Abstract]   [Full Text] [Related]  

  • 9. [Ticlopidine as something more than a platelet antiaggregant].
    Villaverde C; Cánovas M; Padró T; Navarro C
    Arch Farmacol Toxicol; 1984 Aug; 10(2):121-32. PubMed ID: 6517621
    [No Abstract]   [Full Text] [Related]  

  • 10. Rationale for the use of drugs inhibiting platelet function in claudicating patients with atherosclerotic leg arteries.
    Verstraete M
    Agents Actions Suppl; 1984; 15():173-87. PubMed ID: 6091423
    [No Abstract]   [Full Text] [Related]  

  • 11. Ex vivo effects of ticlopidine on human platelets: inhibition of fibrinogen binding by a mechanism independent of thromboxane formation.
    Iovine C; d'Avenia V; Turco S; Mattioli PL; di Minno G
    Agents Actions Suppl; 1984; 15():105-7. PubMed ID: 6592941
    [No Abstract]   [Full Text] [Related]  

  • 12. Ticlopidine: quo vadis?
    Agents Actions Suppl; 1984; 15():1-312. PubMed ID: 6592940
    [No Abstract]   [Full Text] [Related]  

  • 13. Ticlopidine and adenylate cyclase.
    Bonne C; Battais E
    Agents Actions Suppl; 1984; 15():88-96. PubMed ID: 6592947
    [No Abstract]   [Full Text] [Related]  

  • 14. [Thrombocytopenia due to antibodies induced by ticlopidine].
    Claas FH; de Fraiture WH; Meyboom RH
    Nouv Rev Fr Hematol (1978); 1984; 26(5):323-4. PubMed ID: 6504695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of ticlopidine on blood fibrinogen and blood viscosity in peripheral atherosclerotic disease.
    Randi ML; Fabris F; Crociani ME; Battocchio F; Girolami A
    Arzneimittelforschung; 1985; 35(12):1847-9. PubMed ID: 4096744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Structural aspects of the kidney in experimental atheromatosis].
    Lasierra J; Sánchez Casajús A; Martínez Peñuela JM; Velázquez E
    Rev Clin Esp; 1984 Apr; 173(1):15-9. PubMed ID: 6739892
    [No Abstract]   [Full Text] [Related]  

  • 17. Antiaggregant effect of ticlopidine in atherosclerotic patients.
    Manotti C; Potì R; Megna A; Poli T; Alberani M
    Farmaco Prat; 1982 Oct; 37(10):325-30. PubMed ID: 7140941
    [No Abstract]   [Full Text] [Related]  

  • 18. The North American ticlopidine aspirin stroke study: structure, stratification variables, and patient characteristics.
    Hass WK; Kamm B
    Agents Actions Suppl; 1984; 15():273-8. PubMed ID: 6385651
    [No Abstract]   [Full Text] [Related]  

  • 19. Thrombotic etiology of stress ulcers. 1. The effect of anticoagulant and antiplatelet aggregators in the development of stress ulcers in rats.
    Kumashiro R; Pavlides CA; Kholoussy AM; Matsumoto T
    Am Surg; 1983 Aug; 49(8):417-22. PubMed ID: 6614663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The in vitro effect of ticlopidine on fibrinogen and factor VIII binding to human platelets.
    Lee H; Paton RC; Ruan C; Caen JP
    Thromb Haemost; 1981 Oct; 46(3):590-2. PubMed ID: 6797089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.